Norepinephrine and schizophrenia: a new hypothesis for antipsychotic drug action.
Breier
A
A
Section on Clinical Studies, National Institute of Mental Health, Bethesda, Maryland 20892, USA.
Elman
I
I
Goldstein
D S
DS
D014150:Antipsychotic Agents / Q000627:therapeutic use*; D003024:Clozapine / Q000627:therapeutic use*; D005476:Fluphenazine / Q000627:therapeutic use*; D006801:Humans; D008734:Methoxyhydroxyphenylglycol / Q000031:analogs & derivatives / Q000097:blood; D009638:Norepinephrine / Q000097:blood / Q000378:metabolism*; D012044:Regression Analysis; D012559:Schizophrenia / Q000188:drug therapy* / Q000378:metabolism*; D013997:Time Factors
D014150:Antipsychotic Agents; D008734:Methoxyhydroxyphenylglycol; D003024:Clozapine; D005476:Fluphenazine; C010117:3,4-dihydroxyphenylglycol; D009638:Norepinephrine